Revvity Inc. logo

Revvity Inc. (RVTY)

Market Closed
29 Jul, 20:00
NYSE NYSE
$
94. 47
-0.57
-0.6%
$
11.72B Market Cap
- P/E Ratio
0.28% Div Yield
2,303,244 Volume
- Eps
$ 95.04
Previous Close
Day Range
94.06 97.11
Year Range
87.7 129.5
Want to track RVTY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
RVTY Stock Falls Despite the Latest Launch of Automated Instrument

RVTY Stock Falls Despite the Latest Launch of Automated Instrument

Revvity unveils IDS i20, a fully automated immunodiagnostics platform designed to enhance lab efficiency and expand specialty testing.

Zacks | 2 months ago
RVTY Rises as Q1 Earnings & Sales Beat Estimates, '25 Sales View Up

RVTY Rises as Q1 Earnings & Sales Beat Estimates, '25 Sales View Up

Revvity's first-quarter results showcase strong growth in Diagnostics business, along with recovery in Life Sciences segmental sales.

Zacks | 3 months ago
Revvity, Inc. (RVTY) Q1 2025 Earnings Call Transcript

Revvity, Inc. (RVTY) Q1 2025 Earnings Call Transcript

Revvity, Inc. (NYSE:RVTY ) Q1 2025 Earnings Conference Call April 28, 2025 8:00 AM ET Company Participants Steve Willoughby - Senior Vice President, Investor Relations Prahlad Singh - President & Chief Executive Officer Max Krakowiak - Senior Vice President & Chief Financial Officer Conference Call Participants Patrick Donnelly - Citi Dan Brennan - TD Cowen Matt Sykes - Goldman Sachs Vijay Kumar - Evercore ISI Catherine Schulte - Baird Daniel Arias - Stifel Dan Leonard - UBS Luke Sergott - Barclays Tycho Peterson - Jefferies Operator Welcome everyone to Q1 2025 Revvity Earnings Conference Call. My name is Sammy, and I will be coordinating your call today.

Seekingalpha | 3 months ago
Revvity (RVTY) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

Revvity (RVTY) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

While the top- and bottom-line numbers for Revvity (RVTY) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks | 3 months ago
Revvity (RVTY) Beats Q1 Earnings and Revenue Estimates

Revvity (RVTY) Beats Q1 Earnings and Revenue Estimates

Revvity (RVTY) came out with quarterly earnings of $1.01 per share, beating the Zacks Consensus Estimate of $0.96 per share. This compares to earnings of $0.98 per share a year ago.

Zacks | 3 months ago
Segmental Performance to Drive RVTY's Q1 Earnings: Is a Beat Likely?

Segmental Performance to Drive RVTY's Q1 Earnings: Is a Beat Likely?

RVTY's first-quarter results are likely to reflect decent performance in the Diagnostics segment. The Life Sciences segment is likely to have faced continued challenges in China.

Zacks | 3 months ago
Earnings Preview: Revvity (RVTY) Q1 Earnings Expected to Decline

Earnings Preview: Revvity (RVTY) Q1 Earnings Expected to Decline

Revvity (RVTY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 3 months ago
Here's Why You Should Retain Revvity Stock in Your Portfolio for Now

Here's Why You Should Retain Revvity Stock in Your Portfolio for Now

RVTY's strong product portfolio raises optimism about the stock.

Zacks | 3 months ago
Revvity Stock Tumbles Despite Expanding Genomics England Alliance

Revvity Stock Tumbles Despite Expanding Genomics England Alliance

RVTY expands its alliance with Genomics England to boost newborn genomic sequencing research, aiming to enhance early diagnosis and healthcare outcomes.

Zacks | 4 months ago
RVTY Q4 Earnings Beat Estimates, Sales Miss, Segments Robust

RVTY Q4 Earnings Beat Estimates, Sales Miss, Segments Robust

Revvity's fourth-quarter results showcase strong growth in Diagnostics business, along with recovery in Life Sciences segmental sales.

Zacks | 5 months ago
Revvity (RVTY) Reports Q4 Earnings: What Key Metrics Have to Say

Revvity (RVTY) Reports Q4 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Revvity (RVTY) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks | 5 months ago
Revvity, Inc. (RVTY) Q4 2024 Earnings Call Transcript

Revvity, Inc. (RVTY) Q4 2024 Earnings Call Transcript

Revvity, Inc. (NYSE:RVTY ) Q4 2024 Earnings Conference Call January 31, 2025 8:00 AM ET Company Participants Steve Willoughby - Senior Vice President, Investor Relations Prahlad Singh - President & Chief Executive Officer Max Krakowiak - Senior Vice President & Chief Financial Officer Conference Call Participants Doug Schenkel - Wolfe Research Vijay Kumar - Evercore ISI Patrick Donnelly - Citi Michael Ryskin - Bank of America Puneet Souda - Leerink Partners Matt Sykes - Goldman Sachs Luke Sergott - Barclays Andrew Cooper - Raymond James Catherine Schulte - Baird Dan Brennan - TD Cowen Operator Hello, everyone, and welcome to Revvity's Fourth Quarter 2024 Earnings Call. My name is Lydia, and I will be your operator today.

Seekingalpha | 5 months ago
Loading...
Load More